Noevir Holdings Co., Ltd. appointed Ikkou Yoshida as Vice President and Representative Director, effective December 9, 2025. Ikkou Yoshida was previously Managing Director. Ikkou Yoshida was born on June 10, 1957.

He joined Noevir Co., Ltd. in January 1982. In December 2007, he became Director, General Manager of Management Strategy Department, Head of the Public & Investor Relations Department. In December 2009, he was Director and Senior Executive Officer, General Manager of Management Strategy Department.

In March 2011, he retired as Director. In December 2013, he was Director and Senior Executive Officer, General Manager of Management Strategy Department, General Manager of Public & Investor Relations Department. In December 2014, he was Director, Management Strategy and Public & Investor Relations.

In September 2021, he became Managing Director, Administrative. In December 2022, he was Managing Director of Noevir Holdings Co., Ltd. In December 2025, he became Vice President and Representative Director (current). As of December 9, 2025, the management structure also includes Takeshi Okura as Managing Director formerly Director Internal Auditor, Kouzou Matsushita as Director, and President and CEO of TOKIWA Pharmaceutical Co., Ltd., and Akihiro Keyari as Director, and President and CEO of Noevir Co., Ltd.